MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Useful Cognitive-Motor Dual Task Paradigm in Prodromal and Manifest HD

EG. Churchill, J. Corey-Bloom, A. Hall, C. Snell, A. Smirnova, SB. Hughes, PE. Gilbert, DJ. Goble (San Diego, USA)

Meeting: 2022 International Congress

Abstract Number: 631

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features, Cognitive dysfunction

Category: Huntington's Disease

Objective: To investigate whether a cognitive-motor dual task (DT) paradigm uncovers deficits in balance in Huntington’s disease (HD) and, more importantly, prodromal HD, compared to healthy adults (HA).

Background: HD is a progressive neurodegenerative disease characterized by motoric, behavioral, and cognitive disturbances. HD individuals have increased difficulty with balance as the disease progresses. Adding a simultaneous cognitive tax to a balance assessment (so called DT paradigm) may have a deleterious effect on the motor testing, which can be expressed in terms of a Dual Task Cost (DTC) and measured as a percent worsening. DTC is calculated as the relative ratio of single task (ST) to DT, controlling for ST performance: DTC= (ST − DT)/ST x100.

Method: Balance under ST and DT conditions was examined using the BTrackS Balance Plate and Balance software in 28 individuals with HD, 8 individuals with prodromal HD (Pro-HD), and 20 HA. Participants stood on the balance board for two twenty second intervals where the first interval measured the ST condition and the second interval measured the DT condition. During the DT condition, patients were simultaneously administered the Paced Auditory Serial Addition Test (PASAT). Eyes-open DTC was determined by calculating the percent change in Total Body Sway (TBS) from the no PASAT to the PASAT condition.

Results: Subject groups were well-matched with regards to age and education. Mean CAP score was 475.64 for the HD and 356.14 for the Pro-HD individuals. Mean TBS in the EO DT condition was 20.7 cm for HA; 35.00 cm for Pro-HD, and 58.50 cm for HD individuals. Eyes-open DTC was minimal (1.95%) for the HA individuals; whereas individuals with HD showed 63.78% (p<.001) worsening and, more importantly, Pro-HD individuals showed 43.81% (p=.004) worsening compared to HA when the concurrent cognitive task was administered.

Conclusion: The addition of a cognitive task to individuals’ balance assessment resulted in a significant DTC for the HD and pro-HD cohorts, not seen in NC. It is likely that this interference more accurately reflects real life performance and may have additional value for estimating transition to manifest disease, appraising fall risk, or serving as a valid outcome measure in both observational and interventional trials in HD.

To cite this abstract in AMA style:

EG. Churchill, J. Corey-Bloom, A. Hall, C. Snell, A. Smirnova, SB. Hughes, PE. Gilbert, DJ. Goble. A Useful Cognitive-Motor Dual Task Paradigm in Prodromal and Manifest HD [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/a-useful-cognitive-motor-dual-task-paradigm-in-prodromal-and-manifest-hd/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-useful-cognitive-motor-dual-task-paradigm-in-prodromal-and-manifest-hd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley